Krilogy Financial’s iShares iBonds Dec 2036 Term Corporate ETF IBCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.2M Buy
219,263
+15,578
+8% +$382K 0.14% 112
2026
Q2
$5.12M Buy
+203,685
New +$5.12M 0.15% 117

Other funds holding IBCB

Krilogy Financial's IBCB Position: Q3 2026 in Review

Krilogy Financial increased its iShares iBonds Dec 2036 Term Corporate ETF (IBCB) stake by 7.6% in Q3 2026, buying an estimated $382K and bringing the position to 219,263 shares worth $5.2M. The position accounts for 0.14% of the portfolio, ranked #112.

Krilogy Financial first reported a position in IBCB in Q2 2026 and has held it in 2 quarters since. 42 funds tracked by Wall St. Rank hold IBCB as of Q3 2026.

  • Krilogy Financial held 219,263 shares of iShares iBonds Dec 2036 Term Corporate ETF worth $5.2M as of Q3 2026.
  • Krilogy Financial bought 15,578 iShares iBonds Dec 2036 Term Corporate ETF shares in Q3 2026, an estimated $382K.
  • iShares iBonds Dec 2036 Term Corporate ETF made up 0.14% of Krilogy Financial's portfolio in Q3 2026, its #112 holding.
  • Krilogy Financial first reported a position in iShares iBonds Dec 2036 Term Corporate ETF in Q2 2026 and has held it in 2 quarters since.
  • 42 funds tracked by Wall St. Rank held iShares iBonds Dec 2036 Term Corporate ETF as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.